Revolution Medicines, Inc 10-Q for FY2024 Q2
Revolution Medicines, Inc. (RVMD)
10-Q
2024-08-07
For: 2024-06-30
View Original
Added on
April 10, 2026
About this 10-Q
Revolution Medicines, Inc filed this 10-Q on August 7, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).
Headline figures
Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $3.82M a year earlier
- Net loss
- $133.23M
- compared with a net loss of $98.3M a year earlier
- Diluted EPS
- -$0.81
- compared with -$0.92 a year earlier